We first found the expression of GNL3L in 33 cancers in this research, correlation with molecular subtypes and clinical stages in human cancers, genetic variants in human cancers, and copy number alteration (CNA), and we used associated gene enrichment analysis to discuss the prognostic significance of GNL3L. Here, GNL3L is linked to cancer.